Aristo Bio-Tech and Lifescience Past Earnings Performance
Past criteria checks 5/6
Aristo Bio-Tech and Lifescience has been growing earnings at an average annual rate of 31.4%, while the Chemicals industry saw earnings growing at 14.3% annually. Revenues have been growing at an average rate of 47.3% per year. Aristo Bio-Tech and Lifescience's return on equity is 15.4%, and it has net margins of 1.8%.
Key information
31.4%
Earnings growth rate
26.1%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 47.3% |
| Return on equity | 15.4% |
| Net Margin | 1.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Doing What It Can To Lift Shares
Oct 30
Is Aristo Bio-Tech and Lifescience (NSE:ARISTO) Using Too Much Debt?
Aug 22Potential Upside For Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Not Without Risk
Jun 29If EPS Growth Is Important To You, Aristo Bio-Tech and Lifescience (NSE:ARISTO) Presents An Opportunity
Mar 22Revenue & Expenses Breakdown
How Aristo Bio-Tech and Lifescience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,266 | 59 | 21 | 0 |
| 30 Jun 24 | 2,859 | 49 | 29 | 0 |
| 31 Mar 24 | 2,451 | 39 | 37 | 0 |
| 31 Dec 23 | 2,334 | 37 | 49 | 0 |
| 30 Sep 23 | 2,216 | 36 | 63 | 0 |
| 30 Jun 23 | 2,197 | 36 | 60 | 0 |
| 31 Mar 23 | 2,179 | 36 | 58 | 0 |
| 31 Mar 22 | 1,658 | 14 | 54 | 0 |
| 31 Mar 21 | 1,672 | 11 | 36 | 0 |
| 31 Mar 20 | 2,012 | 10 | 41 | 0 |
| 31 Mar 19 | 2,017 | 28 | 51 | 0 |
Quality Earnings: ARISTO has high quality earnings.
Growing Profit Margin: ARISTO's current net profit margins (1.8%) are higher than last year (1.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARISTO's earnings have grown significantly by 31.4% per year over the past 5 years.
Accelerating Growth: ARISTO's earnings growth over the past year (64.6%) exceeds its 5-year average (31.4% per year).
Earnings vs Industry: ARISTO earnings growth over the past year (64.6%) exceeded the Chemicals industry 8%.
Return on Equity
High ROE: ARISTO's Return on Equity (15.4%) is considered low.